TGF Beta 1+2+3 Antibody, Cy7 Conjugated

Cy7

Cy7

7040

None

P01137

IF(IHC-P)

anticorps

Unmodified

Polyclonal

280-330/390

743nm/767nm

1ug per 1ul

TGF Beta 1+2+3

Human, Mouse, Rat

IF(IHC-P)(1:50-200)

Polyclonal antibody

Extracellular, Secreted

Conjugated Primary Antibodies

Rabbit (Oryctolagus cuniculus)

This antibody was purified via Protein A.

TGF Beta 1+2+3 Polyclonal Antibody, Cy7 Conjugated

KLH conjugated synthetic peptide derived from human TGF Beta 1

CED; LAP; DPD1; TGFB; TGFbeta; Transforming growth factor beta-1; TGF-beta-1; TGFB1

These antibodies are excite for emission at 650 nm and detected at a 676 nm wavelengths.

Due to limited amount of testing and knowledge, not every possible cross-reactivity is known.

If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.

Keep the antibody in an aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Store refrigerated at 2 to 8 degrees Celcius for up to 1 year.

This is a highly specific antibody against TGF Beta 1+2+3. This antibody will preferentially react with TGFB1, but will also detect TGFB2 (93%) and TGFB3 (86%) based upon sequence similarity.

Multifunctional protein that controls proliferation, differentiation and other functions in many cell types. Many cells synthesize TGFB1 and have specific receptors for it. It positively and negatively regulates many other growth factors. It plays an important role in bone remodeling as it is a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts. Can promote either T-helper 17 cells (Th17) or regulatory T-cells (Treg) lineage differentiation in a concentration-dependent manner. At high concentrations, leads to FOXP3-mediated suppression of RORC and down-regulation of IL-17 expression, favoring Treg cell development. At low concentrations in concert with IL-6 and IL-21, leads to expression of the IL-17 and IL-23 receptors, favoring differentiation to Th17 cells.